Dioxa -bicyclo [3.2.1]octane-2,3,4-triol derivatives

摘要

Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).